The once-daily tablet regimen was approved for the treatment of HIV-1 infection. It is the smallest INSTI-based triple-therapy STR available.
Kristi Rosa & Matt Hoffman
Advertisement
Articles by Kristi Rosa & Matt Hoffman
Advertisement
Latest Updated Articles
FDA Approves Bictegravir/FTC/TAF Combination HIV TherapyFebruary 7th 2018
Advertisement
Advertisement
Trending on HCPLive
1
Diabetes Technology at a Turning Point: What’s New and What’s Next, With Rachael Sood, NP
2
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
3
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
4
5 Hepatology Headlines You Missed in May 2026
5